Procaps Group S.A. (PROCF) Financials

PROCF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2023 472.5 million 473.2 million
Sept. 30, 2023 498.6 million 460.1 million
June 30, 2023 490.7 million 458.7 million
March 31, 2023 441.7 million 436.5 million

PROCF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 17.5 million ?
Sept. 30, 2023 33.6 million ?
June 30, 2023 8.4 million ?
March 31, 2023 -7.1 million ?

PROCF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2023 -1.4 million
Sept. 30, 2023 8.2 million
June 30, 2023 27.0 million
March 31, 2023 6.6 million

PROCF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 23.8 million 31.1 million 29.8 million
Sept. 30, 2023 17.6 million 220.7 million -
June 30, 2023 11.5 million 169.6 million -
March 31, 2023 23.0 million 150.0 million -

PROCF Shares Outstanding

No data available :(

PROCF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 8.9 million - 49.2 million -
Sept. 30, 2023 4.2 million - 55.2 million -
June 30, 2023 3.9 million - 46.1 million -
March 31, 2023 3.3 million - 42.8 million -

PROCF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 111.1 million 48.8 million
Sept. 30, 2023 118.4 million 50.0 million
June 30, 2023 110.1 million 48.9 million
March 31, 2023 84.2 million 38.1 million

PROCF

Price: $0.03

52 week price:
0.00
1.40

Earnings Per Share: 0.40 USD

P/E Ratio: 0.06

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 58.4 million

Links: